
è¶ å å·¥é£åãé£ã¹ããšæ»äº¡ãªã¹ã¯ãé«ãŸããç¹ã«å¥³æ§ã®å Žå
å èšäºã¯ãã¡ããã/Click here to read the original article.
27,670人ã®åå è ã察象ãšããæè¿ã®ç ç©¶ã§ã¯ãè¶ å å·¥é£åã®æåéãå€ãã»ã©ã³ã¬ã¹ãããŒã«å€ãäœäžããç¹ã«é«éœ¢ã®å¥³æ§ã§HDLïŒåçã³ã¬ã¹ãããŒã«ïŒã®äœäžãšVLDLïŒæªçã³ã¬ã¹ãããŒã«ïŒã®å¢å ãèŠãããã
æŠèŠ
27,670人ã®åå è ã察象ãšããæè¿ã®ç ç©¶ã§ãè¶ å å·¥é£åïŒUPFïŒã¯ç¹ã«å¥³æ§ã®æ»äº¡ãªã¹ã¯ãé«ããããšãæããã«ãªã£ãã
è¶ å å·¥é£åã®æåéãå€ãã»ã©ãã³ã¬ã¹ãããŒã«ã»ãããã£ãŒã«ãæªããªãã髿¯éãªãèçœïŒHDLïŒïŒåçã³ã¬ã¹ãããŒã«ïŒãæžå°ããè¶ äœæ¯éãªãèçœïŒVLDLïŒïŒæªçã³ã¬ã¹ãããŒã«ïŒãå¢å ããããšããç¹ã«é«éœ¢ã®å¥³æ§ã§æããã«ãªã£ãã
è¶ å å·¥é£åãå€ãæåããŠãã人ã¯ãå¿è¡ç®¡çŸæ£ãªã¹ã¯ã11ïŒ é«ããå åèæ§å¿çŸæ£ãªã¹ã¯ã¯16ïŒ ãè³åäžãªã¹ã¯ã¯4ïŒ é«ãã£ãã
ç ç©¶ã§ã¯ãè¶ å å·¥é£åã®æåã«ããå¥åº·ãžã®æªåœ±é¿ãšããŠã倧人ãšåäŸã®åŒåžåšçŸæ£ãè èé害ã粟ç¥è¡çäžã®åé¡ãç³å°¿ç ãªã©25é ç®ãæããããŠããã
è¶ å å·¥é£åã«ããå«ãŸããçš®åæ²¹ã«å«ãŸãããªããŒã«é žïŒLAïŒã¯ç¹ã«æå®³ã§ãçæ³çã«ã¯æåéã1æ¥5ã°ã©ã 以äžã«ããããšã§ããã
è¶ å å·¥é£åã¯ä»ããã¢ã¡ãªã«ã ãã§ãªãäžçäžã§çŸä»£äººã®é£ç掻ã®äž»èŠãªéšåãå ããããã«ãªã£ãŠããã
æè¿ã®ç ç©¶ã«ãããšã髿åŸåœã§ã¯ããããé£åã1æ¥ã®ãšãã«ã®ãŒæåéã®50ïŒ ãã60ïŒ ãå ããããã«ãªã£ãŠãããäžäœæåŸåœãããã«ããã«ç¶ãã ããã
ããããé åçãªããã±ãŒãžããæ¥œããããã¬ãŒããŒãã€ãŸãæ¶è²»è ã«ãšã£ãŠé åçã§åžå Žæ§ã®é«ãé£åã«ããããã«æå³çã«ã€ããããç¹è³ªãèŠéãããŠã¿ãã°ããããã䟿å©ãªå€§éçç£é£åãå¥åº·ãå±éºã«ããããŠããããšããããã ããã
ããæ°å¹Žãè¶ å å·¥é£åã«é¢ããç ç©¶ã¯å¢ãç¶ããŠãããããã仿¥ã®æ ¢æ§çãªå¥åº·äžå®ã®å¢å ã®åå ãšãªã£ãŠããããšãææãããŠããã
æè¿ã®ã¹ãŠã§ãŒãã³ã®ç ç©¶ããã®ãªã¹ãã«å ãããè¶ å å·¥é£åãç¹ã«å¥³æ§ã®å šæ»å æ»äº¡çãå¢å ããããšãã説åŸåã®ãã蚌æ ã瀺ããŠããã
è¶ å å·¥é£åã¯å šæ»å æ»äº¡ãªã¹ã¯ãå¢å ããããšã®ç ç©¶çµæ
2024幎10æã«ãClinical Nutritionãèªã«çºè¡šããããã®ç ç©¶ã¯ãè¶ å å·¥é£åã®æåãæ»äº¡çã«åãŒãååç圱é¿ãè§£æããããšãç®çãšãããã®ã§ããã
ç ç©¶è ãã¯ã1991幎ã«éå§ããã27,670人ãåå ããMalmö Diet and Cancer cohort studyã®ããŒã¿ã䜿çšããã
åå è ã¯ã1é±éæ¯æ¥ã®é£äºãèšé²ããé£äºæ¥èšãã€ããããæ±ããããé£äºå 容ã«ã€ããŠãã€ã³ã¿ãã¥ãŒããããè¡æ¶²ãµã³ãã«ãæ¡åãããåæãããã
ãã¥ãŒã¹ã¡ãã£ã«ã«ãã®èšäºã«ããã°
ãé£äºé ç®ã®åæã«ãããšãUPFã¯ã³ããŒãã®ç·é£åæåéã®13.4ïŒ ãå ããŠãããUPFã®æåéãå€ãåå è ã¯ã女æ§ãé«éœ¢è ãéå«ç è ãäœã¢ã«ã³ãŒã«æåè ã§ããåŸåã匷ãã£ããã
ç ç©¶è ãã¯ãè¡æ¶²æ€æ»çµæãåæããçµæãè¶ å å·¥é£åã®æåéãå€ãã»ã©ãHDLïŒåçã³ã¬ã¹ãããŒã«ïŒã®æžå°ãVLDLïŒæªçã³ã¬ã¹ãããŒã«ïŒã®å¢å ãªã©ãã奜ãŸãããªãè質ãããã¡ã€ã« ããšé¢é£ããŠããããšãçºèŠããã
ãããã®ç¥èŠã¯ãè¶ å å·¥é£åã®æåãšãå¿è¡ç®¡çŸæ£ããããåŒåžåšçŸæ£ã«ããå šæ»äº¡ãæ©çºæ»äº¡ãåå 奿»äº¡ãšã®éã«éç·åœ¢ãªæ£ã®é¢é£ãããããšã瀺ããŠããã女æ§ããã³é«éœ¢è ã§ã¯ãç·æ§ã«æ¯ã¹ãŠãã匷ãé¢é£æ§ãèªããããã
ç ç©¶èè ãã¯æ¬¡ã®ããã«å ±åããŠããïŒ
ãUPFsã¯ããããªãŠã ãèèªãå ç³ããšãã«ã®ãŒãé«ãããšãå€ãããé£ç©ç¹ç¶ããã¿ãã³ãåŸ®éæ é€çŽ ã¯äœããããã«ãUPFã«å«ãŸããäžè¬çã«äœ¿çšãããŠããé£åæ·»å ç©ïŒä¹³åå€ã人工ç峿ãªã©ïŒãUPF補é äžã«æ°ãã«çºçããååç©ïŒã¢ã¯ãªã«ã¢ãããªã©ïŒãé£åå è£ ããç§»è¡ããæ±æç©è³ªïŒãã¹ãã§ããŒã«Aãªã©ïŒããUPFã®å¥åº·ãžã®æªåœ±é¿ã«å¯äžããŠããå¯èœæ§ããããã
è¶ å å·¥é£åãçè§£ãã
ä»åã®èª¿æ»ã§ã¯ãåå è ã®å å·¥é£åæåéãæ§æããäž»ãªãµãã°ã«ãŒããšããŠãã§ãã·ãé£åãšæé£çšã·ãªã¢ã«ïŒ26ïŒ ïŒã飲æïŒ23.3ïŒ ïŒãç ç³è£œåïŒ18.4ïŒ ïŒããœãŒã¹ãšèèªïŒ15.5ïŒ ïŒãèãšéïŒ13.6ïŒ ïŒãæããããŠããããããã¯ãã¹ãŠ ãNOVA4é£å ãã«åé¡ãããã
NOVA4é£åãšã¯ïŒç°¡åã«èšããšãã»ãšãã©ã®é£åã¯ãèã§ããããå€ãã®å å·¥ãçµãŠãããäžã®äžã«ã¯ããªãã®æ°ã®å å·¥é£åããããããå°éå®¶ã¯ãã©ã®é£åãè¶ å å·¥é£åã«åé¡ãããã©ã®é£åãåã«å å·¥ããããã®ããåºå¥ããã®ã«åœ¹ç«ã€äžé£ã®åºæºãå¿ èŠãšããŠããã
ããã§ããã©ãžã«ã®ç ç©¶è ããŒã ããå 工床åãã«åºã¥ããŠå å·¥é£åãåé¡ããNOVAåé¡ã·ã¹ãã ïŒãã«ãã¬ã«èªã®ãNova classificaçãoããã€ãŸããæ°ããåé¡ãã«ç±æ¥ããïŒãèæ¡ããã
NOVAåé¡ã®æŠèŠã¯ä»¥äžã®éãïŒ
NOVA1ïŒæªå å·¥ãŸãã¯æå°éã®å å·¥ãæœããé£åïŒ-ä¿åæ§ã調çãããããåäžããããããå å·¥ãä¿åãæå°éã«æããé£çšåæ€ç©æ§é£åïŒããŒã«ããŒãïŒã
NOVA 2ïŒå å·¥ãããæççŽ æïŒ-ç²ç ã粟補ãå§æŸãçµããã®ãèèãå¡©ãç ç³ããã¿ãŒãæ€ç©æ²¹ãªã©ã該åœããã
NOVA3ïŒå å·¥é£åïŒ - NOVA1ãš2ãçµã¿åãããŠäœããããã®ã§ãã°ã«ãŒã1ã®é£åã«ã°ã«ãŒã2ã®é£åãå ãããèä¹ æ§ãšå®èœæ§ ããé«ããŠããã
NOVA4ïŒè¶ å å·¥é£åããã³é£²æïŒ-ã°ã«ãŒã1ã®æåã¯ã»ãšãã©å«ãŸããŠããããã°ã«ãŒã2以å€ã®çããæ·»å ç©ã䜿çšããå·¥æ¥ç補å€ã§ããã
NOVA4é£åïŒè¶ å å·¥é£åïŒã¯ãå·èµããªããŠãä¿åæéãé·ããå®¶åºã§ã¯åçŸã§ããªãããã«èšèšãããŠãããã©ãã«ã確èªãããšãéåžž5çš®é¡ä»¥äžã®äººå·¥çãªåææã䜿çšãããŠããããšããããã
è¶ å å·¥é£åã®æå®³æ§ã匷調ããç ç©¶ã¯ãä»å玹ä»ãããã®ãåããŠã§ã¯ãªãã
ç ç©¶è ãã¡ãææããŠããããã«ã"2019幎以éãæ°ããªã³ããŒãç ç©¶ã...UPFæåãšå šæ»å æ»äº¡çã®éã«æ£ã®é¢é£ã瀺ããŠãããã
以äžãåããæè¿çºè¡šãããããããã®é£åã®æªåœ±é¿ã詳述ãã2ã€ã®è«æã«ã€ããŠè¿°ã¹ãã
è¶ å å·¥é£åã¯å¿è¡ç®¡çŸæ£ã®ãªã¹ã¯ãé«ãã
äžèšã§ç޹ä»ããç ç©¶ã§ã¯ãè¶ å å·¥é£åã«é¢é£ããå±éºå åã®äžã€ãšããŠå¿è¡ç®¡ç³»çŸæ£æ»äº¡çã«èšåããŠãããããã®å¹æãè£ä»ããå è¡ç ç©¶ãããã
Lancetãèªã«æ²èŒããããã®ç ç©¶ã¯ãè¶ å å·¥é£åãšå¿èçŸæ£ãããªãã¡å¿è¡ç®¡çŸæ£ïŒCVDïŒãå åèæ§å¿çŸæ£ïŒCHDïŒãè³åäžãšã®é¢é£ãæããã«ããããã3ã€ã®ååãã³ããŒãç ç©¶ã調æ»ãããã®ã§ããã
ã³ããŒãç ç©¶ã«ã¯ãå»çåŸäºè 75,735人ãåå ããã2ã€ã®ç ç©¶ã¯å¥³æ§ã®çè·åž«ã§æ§æããããã1ã€ã¯ç·æ§ã®å»çåŸäºè ã§æ§æãããã
ç ç©¶è ãã¯ã2ã4幎ããšã«åå è ã®é£åæåéãšå¥åº·ç¶æ ãè©äŸ¡ããããã®çµæãè¶ å å·¥é£åãæãå€ãé£ã¹ãŠãã人ã¯ãCVDã®ãªã¹ã¯ã11ïŒ ãCHDã®ãªã¹ã¯ã16ïŒ ãè³åäžã®ãªã¹ã¯ã4ïŒ é«ãããšãããã£ãã
ããã«ç ç©¶è ãã¯ãä»åœã®è«æãã³ããŒãç ç©¶ã®ã·ã¹ãããã£ãã¯ã¬ãã¥ãŒãšã¡ã¿ã¢ããªã·ã¹ãè¡ãããã®çµæãè£ä»ããããã®çµæãè¶ å å·¥é£åãå€éã«æåãã被éšè ã¯ãCVDãªã¹ã¯ã17ïŒ ãCHDãªã¹ã¯ã23ïŒ ãè³åäžãªã¹ã¯ã9ïŒ é«ãããšã倿ããã
èè ãã«ãããš
ãå žåçãªUPFïŒç ç³å ¥ã飲æãå å·¥èããã¡ãŒã¹ãããŒããªã©ïŒã¯ããšãã«ã®ãŒå¯åºŠãé«ããCVDãªã¹ã¯å åãšããŠç¢ºç«ããŠããå ç³ã飜åèèªããããªãŠã ãå€ãå«ãã
ãé£åå å·¥ã«çŠç¹ãåœãŠããã®ã§ã¯ãªãããç ç³å ¥ã飲æãå å·¥èãšCVDãšã®é¢é£ã¯ã人工çå³æå ¥ã飲æãšåæ§ã«ãå€ãã®æç®ã§äžè²«ããŠææãããŠããã補é ãå è£ æã«UPFã«æ··å ¥ããååç©ãCVDãªã¹ã¯ãäžæãããå¯èœæ§ãããã
人工çå³æå ¥ã飲æãšå å·¥èã¯ç¹ã«æå®³ã§ããäžæ¹ãéŠã°ããã¹ããã¯ã乳補åã䜿ã£ããšãŒã°ã«ãããã¶ãŒãã¯ãªã¹ã¯ãäœãã£ãã
è¶ å å·¥é£åã«é¢é£ãã25ã®æå®³ãªå¥åº·çµæ
6æã«çºè¡šãããç ç©¶ã®èè ãã¯ãè¶ å å·¥é£åã®æ¶è²»ã«é¢ããæ¢åã®ã¡ã¿ã¢ããªã·ã¹ãè«æããè¶ å å·¥é£åã®èªçãã2023幎ãŸã§ã®å¹ åºãæéã«ããã£ãŠã¬ãã¥ãŒããã
ãã®çµæã¯é©ãã¹ããã®ã§ãè¶ å å·¥é£åã¯æäººãå°å ãéå°å¹Žã®éã§25ã®å¥åº·äžã®æªãçµæãšé¢é£ããŠããããšã瀺ãããã
ãã®ãã¡ã®ããã€ãã¯ãå¿èç ãç³å°¿ç ã®ããã«ãåè¿°ã®2ã€ã®ç ç©¶ã§èŠãããçµæãšé¡äŒŒããŠããããããããããã®é£åã«é¢é£ããä»ã®ãŠããŒã¯ãªçç¶ãææãããŠããã
åŒåžåšçŸæ£ãè èçŸæ£ãèèçŸæ£ãèè žçŸæ£ã粟ç¥çŸæ£ãªã©ã§ããã
ç ç©¶è ãã¡ã¯ãŸãããªããã®ãããªå¯äœçšãèµ·ããã®ãã«ã€ããŠããã®äœçšæ©åºã®ããã€ãã説æããã
äŸãã°
è¶ å å·¥é£åã«äœ¿çšãããã¿ãŒãã©ãžã³ãã«ã«ãã³ãE-120ãªã©ã®æ·»å ç©ã¯ãççæ§ãµã€ãã«ã€ã³ãéæåå¿ãèªçºããå鳎ã忝çç¶ãåŒãèµ·ããã
è¶ å å·¥é£åã¯é£åæ§é ãå€åããŠãããããäœå å·¥é£åãäžå å·¥é£åãããé«è¡ç³ãåŒãèµ·ããã
è¶ å å·¥é£åã¯ãéé£ãé«ãšãã«ã®ãŒæåãšãã£ãäžå¥åº·ãªé£ç¿æ £ãåŒãèµ·ãããè¶ åžžé£æ¬²ç¹æ§ããæã€ããã«èšèšãããŠããã
ããããŠã¹ç ç©¶ã§ã¯ãããããé£åã«ãã䜿ãããæ·»å ç©ã«ã©ã®ãŒãã³ãç©ºè ¹æè¡ç³å€ã®äžæãšã€ã³ã¹ãªã³æµææ§ãåŒãèµ·ããããšãããã£ãã
ãããã®é£åã飲æã«äœ¿ããã人工ç峿ã®ã¢ã¹ãã«ããŒã ã¯ããã€ç ã®çºçäºé²ã«éèŠãªç¥çµäŒéç©è³ªã®åæãšæŸåºãé»å®³ããã
èè ãã¯æ¬¡ã®ããã«çµè«ããŠããïŒ
ãæã ã®å æ¬çã¬ãã¥ãŒãšã¡ã¿ã¢ããªã·ã¹ã®æŽæ°ã«ãããUPFæ¶è²»éã®å¢å ãšé¢é£ãã25ã®å¥åº·äžã®æå®³è»¢åž°ãåå®ãããããã®ãã¡ãè æ©èœäœäžãšå°å ããã³é幎ã®å鳎ã¯ãUPFã®æ¶è²»éãå€ãããšãšç¢ºå®ã«é¢é£ããŠããã
ããããã®ç¥èŠã¯ãUPFã®æ¶è²»éãå°ãªãé£äºãã¿ãŒã³ã«ã¯ãå šç²ç©ç©ãæç©ãéèãåµãèãçä¹³ãªã©ã®å 工床ã®äœãé£åã®æ¶è²»éãå€ãããšãå«ãŸããå¹ åºãå ¬è¡è¡çäžã®å©çãããããå¯èœæ§ãããããšã瀺åããŠãããã
è¶ å å·¥é£åã«å«ãŸããåææ·»å ç©ãããæå®³ãªæå
äžèšã®ç ç©¶ã®å€ãã¯ãè¶ å å·¥é£åã®è£œé ã«äœ¿ãããæ·»å ç©ã人工çãªåææãããããæå®³ãªåœ±é¿ã匷調ããŠããã
ãããã®é£åãæåãããã³ã«ãåæéŠæãéºäŒåçµã¿æãååç©ã蟲è¬ã®ãããªæ±æç©è³ªããã¹ãã§ããŒã«AïŒBPAïŒã®ãããªå åæ³æ¹ä¹±ååŠç©è³ªã«ãããããŠããã®ã ã
ãããããããã®é£åã«å€ãå«ãŸããæå€§ã®å®³ãããããç¹å®ã®æåãããããªã¡ã¬6èèªé žã®ãªããŒã«é žã§ããã
ãªããŒã«é žã¯çš®åæ²¹ã«å€ãå«ãŸãããããã®è¶ å å·¥é£åãäœãéã«å€§éã«äœ¿çšããããå å·¥é£åå šäœã®ã«ããªãŒã®çŽ50ïŒ ä»¥äžããçš®åæ²¹ã«ç±æ¥ããã
LAã¯å€äŸ¡äžé£œåèèªã§ãããè€æ°ã®äºéçµåãæã€ããååŠçã«äžå®å®ã§é žåããããããç¹ã«çްèã®ãšãã«ã®ãŒç£çæã«çºçããæŽ»æ§é žçŽ çš®ïŒROSïŒã®ååšäžã§ã¯é žåããããããšããç¹åŸŽãããã
ãã®é žåã¹ãã¬ã¹ã¯ãããªãŒã©ãžã«ã«ãçæããŠçްèé害ãåŒãèµ·ããALEsïŒadvanced lipoxidation end-productsïŒã®åœ¢æã«ã€ãªããããããã®ããªãŒã©ãžã«ã«ã¯ã现èèãããã³ã³ããªã¢ãã¿ã³ãã¯è³ªãDNAãå·ã€ããçŽ°èæ©èœå šäœãæãªãã
LAã¯ãŸããäœå ã§é žåLA代è¬ç£ç©ïŒOXLAMïŒã«åè§£ãããå¥åº·ã«éå€§ãªæªåœ±é¿ãåãŒãæå®³ãªä»£è¬ç£ç©ãšãªããALEsãšOXLAMsã¯ãšãã«ãã»ãšãã©ã®æ ¢æ§çŸæ£ã®ç¹åŸŽã§ããããã³ã³ããªã¢æ©èœé害ãåŒãèµ·ããã
ãŸããLAã¯äœå ã§ã®åæžæãéåžžã«é·ãããã®ããç ç³ãããå¥åº·ã«æªåœ±é¿ãåãŒããåæžæã¯çŽ600ïœ680æ¥ãã€ãŸã2幎è¿ãããããã€ãŸããäœå ã®LAã®95ïŒ ãå¥åº·çãªèèªã«çœ®ãæããã«ã¯ãçŽ6幎ãããããšã«ãªãã
LAã®æåéãã§ããã ãæããããšããå§ãããã®ã¯ãã®ããã§ãã
ãã®ããã«ã¯ãé£äºããè¶ å å·¥é£åãçš®åæ²¹ããããé¡ããã¹ãŠåãé€ãå¿ èŠããããçæ³çã«ã¯ã1æ¥ã«5ã°ã©ã ã®LAãæåããããšã ãã2ã°ã©ã ãŸã§äžããããšãã§ããã°ãããã«è¯ãã
ãªãªãŒããªã€ã«ããã«ããã¢ãããã®ãããªäžäŸ¡äžé£œåèèªé žïŒMUFAïŒã¯ããªã¬ã€ã³é žãå«ããããæåãå¶éããããšããå§ãããŸãã
å å·¥ãããŠããªãé£åãéžã³ãé£çæŽ»ãæ¹åããã
çæŽ»ããè¶ å å·¥é£åããªããã®ãæ©ããã°æ©ãã»ã©ãäžè¿°ãããããªå¥åº·äžã®åé¡ãåé¿ã§ããå¯èœæ§ãé«ãŸããŸããå€ãã®äººãããã§ããããã«ãè¶ å å·¥é£åã¯é£ç掻ã®å€§éšåãå ããŠããã
äŸãã°ãå å·¥ãããããããããã¹ãã¯ãããŒãããã«ãŒãã¹ã©ã€ã¹ãéèã¹ãã£ãã¯ãªã©ããããã«ã·ãŒãªã¹ããã¯ã«å€ããŠã¿ãŸããããå®¶ã«ããçé žé£²æã®ãããªç³åã®å€ã飲ã¿ç©ããã¹ãŠåãé€ãã代ããã«çŽç²ãªæ°Žããã«ãŒããžã¥ãŒã¹ãéžã³ãŸãããã
ã³ãã¯ãæ¯é£ã®é£äºããå©çãåŸããã£ã³ã¹ã ãšèããããšã ãããŒã«ããŒããéžã¶ããšã§ãè¶ å å·¥é£åã®å±éºæ§ãé¿ããããšãã§ããã ãã§ãªããããããããšã§æ é€ãè£çµŠããå¥åº·ãç¶æããããšãã§ããã